Financial statements Pdg Cetus Pharma
Balance sheet data of PDG CETUS PHARMA
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 1 131 067,44 | 2 088 124,97 | 1 731 662,25 | 817 502,57 | 801 431,00 | 426 752,56 |
A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 59 129,60 | 22 584,55 |
B. Current assets | 1 131 067,44 | 2 088 124,97 | 1 731 662,25 | 817 502,57 | 742 301,40 | 404 168,01 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
Total liabilities | 1 131 067,44 | 2 088 124,97 | 1 731 662,25 | 817 502,57 | 801 431,00 | 426 752,56 |
A. Equity | 1 008 105,20 | 1 635 513,60 | 1 392 228,30 | 662 660,13 | 748 994,73 | 349 961,18 |
B. Liabilities and provisions for liabilities | 122 962,24 | 452 611,37 | 339 433,95 | 154 842,44 | 52 436,27 | 76 791,38 |
I. Long-term liabilities | - | - | - | 0,00 | 0,00 | - |
II. Short-term liabilities | - | - | - | 151 304,71 | 52 436,27 | 76 791,38 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.